Skip to main content

Table 1 Relationship between the clinical features and mean EpCAM + p75NTR+ or EpCAM + p75NTR− CTC counts in patients who received chemotherapy or chemoradiotherapy

From: Detection of circulating tumor cells by p75NTR expression in patients with esophageal cancer

Characteristics

Number

EpCAM + p75NTR+ (average ± SD)

p value

EpCAM + p75NTR− (average ± SD)

p value

Male/female

9/4

16.4 ± 19.7/14.0 ± 14.4

0.764

26.0 ± 34.9/13.3 ± 14.1

0.504

Age ≥65/>65

5/8

22.8 ± 11.6/11.3 ± 11.9

0.114

38.2 ± 44.0/12.06 ± 11.7

0.131

Ce-Ut/Mt-Ae

2/11

19.0 ± 20.5/15.0 ± 12.2

0.666

2.0 ± 2.8/25.7 ± 31.4

0.325

T 0–2/3–4

1/12

7.0/16.4 ± 13.0

0.501

0/23.9 ± 30.6

0.468

N 0/1–3

1/12

7.0/16.4 ± 13.0

0.501

0/23.9 ± 30.6

0.468

M 0/1

8/5

7.1 ± 5.9/29.4 ± 6.4

*0.003

19.5 ± 20.8/26.2 ± 43.7

0.713

Stages 1–2/3–4

1/12

7.0/16.4 ± 13.0

0.501

0/23.9 ± 30.6

0.468

  1. CTC circulating tumor cell, SD standard deviation
  2. *p < 0.05